Three guiding principles drive our pricing decisions.
We deliver local value by collaborating with payers and governments to
offer accessible and affordable medicines, fueling sustainable innovation.
The value our medicines bring is in improving the lives of patients and transforming their health for the future.
We strive to deliver transformational medicines that improve the lives and health of patients. Our medicines help people live longer and improve their quality of life. We work closely with payers such as governments, insurers and other local stakeholders to negotiate the price of our medicines based on their local value — prioritizing health outcomes and the impact our medicines have on a specific society and economy.
Accessible and Affordable
Through active collaboration, we make our medicines readily accessible and affordable for patients and health systems in accordance with specific reimbursement systems and legal guidelines of local communities.
Countries and health systems around the world differ in how they pay for medicines and make them accessible to their citizens. Knowing this, we work with governments and payers, as early as the law allows, to discuss coverage, accelerate availability and provide the best possible access to our medicines. After all, medicines only deliver value when they reach patients who need them.
Sustaining the discovery, development and delivery of transformational medicines is necessary to improve lives for current and future patients in need.
When we succeed at delivering valuable medicines with transformational outcomes, individual patients thrive, and families, countries, communities and societies flourish. Enabling investment in innovation to discover, develop and deliver medicines provides significant benefit to patients today and tomorrow. Fair pricing for valuable therapies fuels the next breakthroughs and cures.